Therefore, nutritional inhibition targeting Asn is used as an anti-cancer strategy, and Gram-negative bacterial asparaginases, like Kidrolase, have been applied to treat acute lymphoblastic leukemia (ALL) (Tabe et al, 2019; Yuan et al, 2024). This evidence concerns the gene ASPG and acute lymphoblastic leukemia.